X
XTL Biopharmaceuticals Ltd. (XTLB)
NCM – Real Time Price. Currency in USD
2.69
+0.04 (1.51%)
At close: Aug 12, 2026, 3:59 PM EDT
2.83
+0.14 (5.20%)
After-hours: Aug 12, 2026, 4:10 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
2.69
+0.04 (1.51%)
At close: Aug 12, 2026, 3:59 PM EDT
2.83
+0.14 (5.20%)
After-hours: Aug 12, 2026, 4:10 PM EDT
No Data
There are no news for this stock.
Cash reserves $0.0 barely cover the upcoming debt maturities $0.0
Total current assets $0.0 are just enough to cover Total current liabilities $0.0, indicating tight liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
The company has no interest-bearing debt, showcasing excellent financial strength
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | N/A | 6.05 | 1.0 | |
| Quick ratio | N/A | 5.63 | 1.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | N/A | 1.04 | 1.0 | |
| Interest coverage | N/A | -16.91 | 10 | |
| Weighted average score | 2.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -996.09 | N/A | -200K | N/A | N/A |
| Operating Income | -877K | -763K | -779K | -1M | N/A |
| Net Income | -1M | -2M | -1M | -765K | N/A |
| EBITDA | -876K | -763K | -579K | -1M | N/A |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | N/A | N/A | N/A | N/A | 1.0 |
| Y/Y | N/A | N/A | N/A | N/A | 1.0 |
| 3y average | 999 | 11.81 | N/A | -29.19 | 4.8 |
| 5y average | 999 | -51.67 | N/A | -19.34 | 3.3 |
| Weighted average score | 2.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |